Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A real-life comparison of pulmonary and nasal outcomes in patients with severe asthma and nasal polyposis treated with T2-biologics
Ulrike Förster‐Ruhrmann, Dafni Stergioudi, Agnieszka J. Szczepek, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 2, pp. 100746-100746
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Effect of Dupilumab in CRSwNP Sinonasal Outcomes from Real Life Studies: A Systematic Review with Meta-analysis
Miguel Rodriguez-Iglesias, Christian Calvo‐Henríquez, Daniel Martín-Jiménez, et al.
Current Allergy and Asthma Reports (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety of Biologics for Chronic Rhinosinusitis With Nasal Polyps: A Meta‐Analysis of Real‐World Evidence
Shiru Cai, Shenglong Xu, Yan Zhao, et al.
Allergy (2025)
Open Access | Times Cited: 1
Chinese Position Paper on Biologic Therapy for Chronic Rhinosinusitis With Nasal Polyps
Mu Xian, Bing Yan, Xicheng Song, et al.
Allergy (2025)
Open Access | Times Cited: 1
Biologics for Chronic Rhinosinusitis—A Modern Option for Therapy
Romică Cergan, Ovidiu Berghi, Mihai Dumitru, et al.
Life (2023) Vol. 13, Iss. 11, pp. 2165-2165
Open Access | Times Cited: 19
Pediatric asthma comorbidities: Global impact and unmet needs
Elham Hossny, Yuichi Adachi, Eleni Anastasiou, et al.
World Allergy Organization Journal (2024) Vol. 17, Iss. 5, pp. 100909-100909
Open Access | Times Cited: 4
Outcome measures for chronic rhinosinusitis with nasal polyps
Ahmad R. Sedaghat, Raewyn G. Campbell, Richard Douglas, et al.
Rhinology Journal (2024)
Open Access | Times Cited: 4
Biological therapy in Chronic rhinosinusitis with nasal polyps
Zeyi Jin, Bing Yan, Luo Zhang, et al.
Expert Review of Clinical Immunology (2025)
Closed Access
Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal polyps
Angélica Tiotiu, Nicolas Migueres, Francisco Javier González‐Barcala, et al.
Respiratory Medicine (2025) Vol. 238, pp. 107979-107979
Closed Access
A real-life evaluation of SNOT-22 domains in a cohort of CRSwNP patients treated with biologic therapies for 12 months
Giulia Costanzo, Andrea Ledda, Giada Sambugaro, et al.
World Allergy Organization Journal (2025) Vol. 18, Iss. 3, pp. 101041-101041
Open Access
Combining Dual Biologics Therapy for Severe Asthma: A Series of Ten Cases
Y.-C. Chen, Lu Wang, Jiaxing Xie
Journal of Asthma and Allergy (2025) Vol. Volume 18, pp. 507-517
Open Access
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective
Marco Caminati, Matteo Maule, Roberto Benoni, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 390-390
Open Access | Times Cited: 3
Severe hypereosinophilia in a patient treated with dupilumab and shift to mepolizumab: the importance of multidisciplinary management. A case report and literature review
Sara Munari, Giulia Ciotti, Walter Cestaro, et al.
Drugs in Context (2024) Vol. 13, pp. 1-11
Open Access | Times Cited: 3
Real Life Observational Study of Treatment Success of Monoclonal Antibodies for Refractory Chronic Rhinosinusitis with Nasal Polyps
Kathrin Gerstacker, Manuel Christoph Ketterer, Till F. Jakob, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 13, pp. 4374-4374
Open Access | Times Cited: 6
Advances in co-pathogenesis of the united airway diseases
Xinjun Xu, Jiali Yin, Yujuan Yang, et al.
Respiratory Medicine (2024) Vol. 225, pp. 107580-107580
Closed Access | Times Cited: 2
Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy
Moritz Z. Kayser, Hendrik Suhling, Jan Fuge, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Biologics Reduce Symptoms of Alcohol Intolerance Better than Aspirin Desensitization in Patients with N-ERD and Nasal Polyps
U. Foerster-Ruhrmann, M Jurkov, Agnieszka J. Szczepek, et al.
Biomedicines (2024) Vol. 12, Iss. 5, pp. 1025-1025
Open Access | Times Cited: 1
Benralizumab Reduces Respiratory Exacerbations and Oral Glucocorticosteroid Dose in Patients with Severe Asthma and Eosinophilic Granulomatosis with Polyangiitis
Carlo Mümmler, Pontus Mertsch, Michaela Barnikel, et al.
Journal of Asthma and Allergy (2024) Vol. Volume 17, pp. 557-572
Open Access | Times Cited: 1
Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
Hendrik Suhling, Dirk Skowasch, Karl‐Christian Bergmann, et al.
World Allergy Organization Journal (2023) Vol. 16, Iss. 12, pp. 100844-100844
Open Access | Times Cited: 2
Outcomes of biological therapy in patients with severe asthma with chronic rhinosinusitis in Saudi Arabia: patients with nasal polyps versus those without nasal polyps
Usama E. Abu Elhassan, Medhat Elnamaky, Abdulaziz Alfifi, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Impact of biological therapies on laboratory outcomes and FEV1 in patients with severe eosinophilic asthma with chronic rhinosinusitis: a real-life study from Saudi Arabia
Usama Abu Elhassan, Salihah Y. Al-Mani, Saad M. Alqahtani, et al.
Multidisciplinary Respiratory Medicine (2024) Vol. 19, Iss. Vol. 19 (2024)
Open Access
Real‐World Evaluation of Asthma Severity Following Endoscopic Sinus Surgery in Chronic Rhinosinusitis Patients
Anyull D. B. Caballero, Estephanía Candelo, Karol Avila‐Castano, et al.
OTO Open (2024) Vol. 8, Iss. 3
Open Access
Effects of Mepolizumab in the treatment of type 2 CRSwNP: a real-life clinical study
Pietro Orlando, Emanuele Vivarelli, Alberto Minzoni, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Open Access
Changes in weight secondary to improved odor perception in chronic rhinosinusitis with nasal polyps’ patients treated with Dupilumab
Cecilia Rosso, Eugenio De Corso, Anastasia Urbanelli, et al.
European Archives of Oto-Rhino-Laryngology (2024)
Open Access
Impact of biological therapies on clinical outcomes in patients with severe eosinophilic asthma with chronic rhinosinusitis: an observational study from Saudi Arabia
Usama E. Abuelhassan, Abdelrahman M. Abdalla, Abdulaziz Alfaifi, et al.
Egyptian Journal of Bronchology (2024) Vol. 18, Iss. 1
Open Access
Olfactory Dysfunction in Chronic Rhinosinusitis with Nasal Polyps: Effect of Treatment with Emphasis on Biological Therapy
Josje Janna Otten, Wytske J. Fokkens, Sietze Reitsma
Current Allergy and Asthma Reports (2024) Vol. 25, Iss. 1
Closed Access
Page 1 - Next Page

Scroll to top